MDxHealth (MDXH) Income from Non-Controlling Interests (2021 - 2023)

MDxHealth (MDXH) posted Income from Non-Controlling Interests of -$587.3 million for Q3 2022, down 381.89% sequentially from -$121.9 million in Q3 2021, and down 381.89% YoY from $208.3 million in Q3 2021.

MDxHealth (MDXH) Income from Non-Controlling Interests (2021 - 2023) Analysis & Trends

MDxHealth has reported Income from Non-Controlling Interests for 2 years, with the latest figure at -$587.3 million in Q3 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Thermo Fisher Scientific 213.77 Bn 209.71 Bn 8.34 Bn 5.00 Mn
2 Danaher 139.78 Bn 135.43 Bn 3.61 Bn -
3 Idexx Laboratories 46.04 Bn 45.85 Bn 779.09 Mn -
4 Agilent Technologies 39.68 Bn 37.88 Bn 990.00 Mn -
5 Iqvia Holdings 39.34 Bn 37.26 Bn 1.44 Bn 2.00 Mn
6 Natera 38.75 Bn 37.65 Bn 696.04 Mn -
7 Illumina 29.90 Bn 28.73 Bn 770.00 Mn -
8 Mettler Toledo International 28.58 Bn 28.53 Bn 650.22 Mn -
9 Quest Diagnostics 26.18 Bn 25.55 Bn 1.03 Bn 14.00 Mn
10 MDxHealth 21.82 Mn -21.33 Mn 16.61 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2023 -486,000.00
Mar 31, 2023 287,000.00
Sep 30, 2022 -587.31 Mn
Sep 30, 2021 -121.88 Mn